TCAIM
gene geneOn this page
Also known as DKFZp313N0621TOAG-1
Summary
TCAIM (T cell activation inhibitor, mitochondrial, HGNC:25241) is a protein-coding gene on chromosome 3p21.31, encoding T-cell activation inhibitor, mitochondrial (Q8N3R3). May regulate T-cell apoptosis.
Located in mitochondrion.
Source: NCBI Gene 285343 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 64 total
- MANE Select transcript:
NM_173826
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25241 |
| Approved symbol | TCAIM |
| Name | T cell activation inhibitor, mitochondrial |
| Location | 3p21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp313N0621, TOAG-1 |
| Ensembl gene | ENSG00000179152 |
| Ensembl biotype | protein_coding |
| OMIM | 620787 |
| Entrez | 285343 |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 11 protein_coding, 3 nonsense_mediated_decay, 3 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000342649, ENST00000383746, ENST00000396078, ENST00000412611, ENST00000417237, ENST00000417768, ENST00000431657, ENST00000444602, ENST00000462230, ENST00000462612, ENST00000469246, ENST00000494638, ENST00000876546, ENST00000876547, ENST00000876548, ENST00000876549, ENST00000876550, ENST00000876551
RefSeq mRNA: 6 — MANE Select: NM_173826
NM_001029839, NM_001029840, NM_001282913, NM_001282914, NM_001282915, NM_173826
CCDS: CCDS2712, CCDS43076
Canonical transcript exons
ENST00000342649 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001218452 | 44367456 | 44367708 |
| ENSE00003461802 | 44407442 | 44409448 |
| ENSE00003478752 | 44354739 | 44354811 |
| ENSE00003516320 | 44401203 | 44401334 |
| ENSE00003605374 | 44357741 | 44357876 |
| ENSE00003621927 | 44400355 | 44400587 |
| ENSE00003624005 | 44396400 | 44396497 |
| ENSE00003667585 | 44361365 | 44361518 |
| ENSE00003677167 | 44396743 | 44396834 |
| ENSE00003691393 | 44392855 | 44392977 |
| ENSE00003849468 | 44338766 | 44338834 |
Expression profiles
Bgee: expression breadth ubiquitous, 249 present calls, max score 91.19.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.2767 / max 107.6608, expressed in 1809 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 36320 | 8.1577 | 1746 |
| 36323 | 8.0377 | 1730 |
| 36324 | 3.1431 | 1393 |
| 36321 | 0.7957 | 525 |
| 36322 | 0.1425 | 45 |
Top tissues by expression
255 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 91.19 | gold quality |
| liver | UBERON:0002107 | 90.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 89.30 | gold quality |
| adrenal tissue | UBERON:0018303 | 89.05 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 88.67 | gold quality |
| islet of Langerhans | UBERON:0000006 | 88.48 | gold quality |
| ventricular zone | UBERON:0003053 | 88.36 | gold quality |
| muscle of leg | UBERON:0001383 | 88.29 | gold quality |
| gastrocnemius | UBERON:0001388 | 87.79 | gold quality |
| ganglionic eminence | UBERON:0004023 | 87.79 | gold quality |
| spinal cord | UBERON:0002240 | 87.73 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.40 | gold quality |
| deltoid | UBERON:0001476 | 87.38 | gold quality |
| secondary oocyte | CL:0000655 | 87.14 | gold quality |
| tibialis anterior | UBERON:0001385 | 87.10 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 86.92 | gold quality |
| metanephros cortex | UBERON:0010533 | 86.88 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 86.87 | gold quality |
| calcaneal tendon | UBERON:0003701 | 86.86 | gold quality |
| monocyte | CL:0000576 | 86.72 | gold quality |
| oocyte | CL:0000023 | 86.71 | gold quality |
| amniotic fluid | UBERON:0000173 | 86.49 | gold quality |
| leukocyte | CL:0000738 | 86.46 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 86.33 | gold quality |
| cortex of kidney | UBERON:0001225 | 86.28 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 86.20 | gold quality |
| biceps brachii | UBERON:0001507 | 86.08 | gold quality |
| gall bladder | UBERON:0002110 | 85.85 | gold quality |
| rectum | UBERON:0001052 | 85.76 | gold quality |
| colonic epithelium | UBERON:0000397 | 85.25 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.79 |
| E-MTAB-4850 | no | 93.46 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
111 targeting TCAIM, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-497-5P | 99.92 | 71.83 | 2674 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-195-5P | 99.90 | 72.81 | 2805 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tcaim | ENSDARG00000079881 |
| mus_musculus | Tcaim | ENSMUSG00000046603 |
| rattus_norvegicus | Tcaim | ENSRNOG00000004085 |
| drosophila_melanogaster | CG13295 | FBGN0035674 |
| drosophila_melanogaster | CG2854 | FBGN0040391 |
| caenorhabditis_elegans | WBGENE00016438 |
Protein
Protein identifiers
T-cell activation inhibitor, mitochondrial — Q8N3R3 (reviewed: Q8N3R3)
Alternative names: Tolerance associated gene-1 protein
All UniProt accessions (2): Q8N3R3, A0A0U1RQT4
UniProt curated annotations — full annotation on UniProt →
Function. May regulate T-cell apoptosis.
Subcellular location. Mitochondrion.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N3R3-1 | 1 | yes |
| Q8N3R3-2 | 2 | |
| Q8N3R3-3 | 3 | |
| Q8N3R3-4 | 4 |
RefSeq proteins (6): NP_001025010, NP_001025011, NP_001269842, NP_001269843, NP_001269844, NP_776187* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027986 | TCAIM | Family |
| IPR027989 | DUF4461 | Domain |
| IPR028031 | DUF4460 | Domain |
Pfam: PF14687, PF14688
UniProt features (29 total): helix 9, strand 9, splice variant 5, sequence conflict 2, chain 1, coiled-coil region 1, turn 1, sequence variant 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8I0K | ELECTRON MICROSCOPY | 2.86 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N3R3-F1 | 79.77 | 0.47 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 96 (showing top):
TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, HNF4_DR1_Q3, YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP, CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN, CSR_EARLY_UP.V1_DN, BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP, chr3p21, CIITA_TARGET_GENES, F10_TARGET_GENES, HOXA7_TARGET_GENES, HOXB6_TARGET_GENES, ID2_TARGET_GENES, NFE2L1_TARGET_GENES, NFKBIA_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): mitochondrion (GO:0005739)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
412 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TCAIM | PTH2 | Q96A98 | 510 |
| TCAIM | SMIM12 | Q96EX1 | 459 |
| TCAIM | CLEC2L | P0C7M8 | 438 |
| TCAIM | BEND7 | Q8N7W2 | 438 |
| TCAIM | ITGA8 | P53708 | 412 |
| TCAIM | ZC3H8 | Q8N5P1 | 409 |
| TCAIM | LRRC40 | Q9H9A6 | 407 |
| TCAIM | SHISA4 | Q96DD7 | 406 |
| TCAIM | BTBD8 | Q5XKL5 | 404 |
| TCAIM | PAMR1 | Q6UXH9 | 403 |
| TCAIM | FAM177A1 | Q8N128 | 402 |
| TCAIM | MNMIP1 | A4FU49 | 398 |
| TCAIM | KRT36 | O76013 | 386 |
| TCAIM | MAN1A1 | P33908 | 382 |
| TCAIM | TIMM21 | Q9BVV7 | 381 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TCAIM | KGD4 | psi-mi:“MI:0914”(association) | 0.350 |
| TCAIM | cutA | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): TCAIM (Proximity Label-MS), MRPS36 (Affinity Capture-MS), OGDHL (Affinity Capture-MS), OGDH (Affinity Capture-MS), TCAIM (Affinity Capture-MS), TCAIM (Affinity Capture-MS)
ESM2 similar proteins: A1A4J7, A2BID5, A2RRP1, A2RV06, B5DF07, E7FAW3, O00750, O15091, O35821, O70167, O70173, O75153, O75800, O76024, O88480, P0DKR2, P82650, Q08CY4, Q1LXZ7, Q28HN9, Q4R366, Q4R7V1, Q58CX2, Q5SW19, Q5TYW4, Q5U249, Q5XGL1, Q66JZ4, Q6AXZ5, Q6DRB1, Q6GPP1, Q7L8L6, Q7TPV4, Q811I0, Q86VS3, Q8BIR2, Q8C7B8, Q8CJF7, Q8IYW2, Q8JZY4
Diamond homologs: P0DKR2, Q66JZ4, Q8N3R3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
64 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1792 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:44358299:T:G | donor_gain | 1.0000 |
| 3:44361364:GGAA:G | acceptor_gain | 1.0000 |
| 3:44361519:G:GA | donor_loss | 1.0000 |
| 3:44361519:G:GG | donor_gain | 1.0000 |
| 3:44361520:TACG:T | donor_loss | 1.0000 |
| 3:44367530:A:AG | acceptor_gain | 1.0000 |
| 3:44367531:G:GG | acceptor_gain | 1.0000 |
| 3:44367707:ACG:A | donor_loss | 1.0000 |
| 3:44367709:G:T | donor_loss | 1.0000 |
| 3:44367709:GTAT:G | donor_gain | 1.0000 |
| 3:44367710:T:G | donor_loss | 1.0000 |
| 3:44392850:TCTA:T | acceptor_loss | 1.0000 |
| 3:44392852:TA:T | acceptor_loss | 1.0000 |
| 3:44392853:A:AG | acceptor_gain | 1.0000 |
| 3:44392853:AG:A | acceptor_loss | 1.0000 |
| 3:44392854:G:GG | acceptor_gain | 1.0000 |
| 3:44392854:GA:G | acceptor_gain | 1.0000 |
| 3:44392854:GAT:G | acceptor_gain | 1.0000 |
| 3:44392854:GATC:G | acceptor_gain | 1.0000 |
| 3:44392976:AGG:A | donor_loss | 1.0000 |
| 3:44392977:GGTAA:G | donor_loss | 1.0000 |
| 3:44392978:G:GA | donor_loss | 1.0000 |
| 3:44392979:T:A | donor_loss | 1.0000 |
| 3:44396493:AAAAG:A | donor_loss | 1.0000 |
| 3:44396494:AAAGG:A | donor_loss | 1.0000 |
| 3:44396495:AAG:A | donor_loss | 1.0000 |
| 3:44396496:AGG:A | donor_loss | 1.0000 |
| 3:44396497:GG:G | donor_loss | 1.0000 |
| 3:44396498:G:A | donor_loss | 1.0000 |
| 3:44396499:T:A | donor_loss | 1.0000 |
AlphaMissense
3311 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:44396401:T:A | W233R | 0.997 |
| 3:44396401:T:C | W233R | 0.997 |
| 3:44396826:T:A | W293R | 0.997 |
| 3:44396826:T:C | W293R | 0.997 |
| 3:44357841:C:G | H44D | 0.995 |
| 3:44361458:T:C | F87L | 0.995 |
| 3:44361459:T:C | F87S | 0.995 |
| 3:44361460:T:A | F87L | 0.995 |
| 3:44361460:T:G | F87L | 0.995 |
| 3:44396446:A:C | S248R | 0.995 |
| 3:44396448:T:A | S248R | 0.995 |
| 3:44396448:T:G | S248R | 0.995 |
| 3:44357853:T:C | F48L | 0.994 |
| 3:44357855:T:A | F48L | 0.994 |
| 3:44357855:T:G | F48L | 0.994 |
| 3:44361380:T:C | S61P | 0.994 |
| 3:44361384:T:C | L62P | 0.994 |
| 3:44361393:T:C | L65S | 0.994 |
| 3:44396441:T:C | L246P | 0.994 |
| 3:44357827:T:C | F39S | 0.993 |
| 3:44357839:T:A | V43E | 0.993 |
| 3:44361373:T:A | N58K | 0.993 |
| 3:44361373:T:G | N58K | 0.993 |
| 3:44357818:T:C | L36S | 0.992 |
| 3:44357843:T:A | H44Q | 0.992 |
| 3:44357843:T:G | H44Q | 0.992 |
| 3:44396828:G:C | W293C | 0.991 |
| 3:44396828:G:T | W293C | 0.991 |
| 3:44396413:T:A | W237R | 0.990 |
| 3:44396413:T:C | W237R | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000085646 (3:44356921 C>A), RS1000102677 (3:44351077 A>G), RS1000137924 (3:44356648 C>G), RS1000140133 (3:44377915 A>C), RS1000170770 (3:44356298 G>A), RS1000172725 (3:44338923 T>G), RS1000220857 (3:44338782 T>C,G), RS1000254671 (3:44401948 G>C), RS1000280920 (3:44378208 C>A), RS1000364825 (3:44409367 A>G), RS1000366325 (3:44364049 C>T), RS1000422052 (3:44371388 T>C), RS1000438523 (3:44409832 C>T), RS1000471343 (3:44340471 T>C,G), RS1000496480 (3:44388200 T>C,G)
Disease associations
OMIM: gene MIM:620787 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005839_8 | Depression | 5.000000e-08 |
| GCST009600_32 | Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) | 4.000000e-08 |
| GCST011494_83 | Daytime nap | 1.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007828 | daytime rest measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, decreases methylation | 5 |
| Acetaminophen | decreases expression | 3 |
| bisphenol A | increases expression | 2 |
| sodium arsenite | decreases expression | 2 |
| entinostat | decreases expression, affects cotreatment | 2 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 2 |
| Cyclosporine | increases expression, decreases expression | 2 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| trichostatin A | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| pentanal | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression, increases expression | 1 |
| belinostat | decreases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression, increases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Zoledronic Acid | increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Catechin | affects cotreatment, increases expression | 1 |
| Cisplatin | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.